iifl-logo

LIC MF Healthcare Fund Regular G

LIC MF Healthcare Fund Regular G

Fund Name

LIC Mutual Fund

Scheme Name

LIC MF Healthcare Fund Regular G

AMC

LIC Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

08-Feb-2019

Fund Manager

Karan Doshi

Net Assets (Rs. cr)

88.29

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

LIC MF Healthcare Fund Regular G - Nav Details

Nav Date

:  17-Sep-2025

NAV [Rs.]

:  29.762

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.

LIC MF Healthcare Fund Regular G- NAV Chart

LIC MF Healthcare Fund Regular G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.73
0.38
4.13
10.7
-0.01
21.22
14.04
18.09
Category Avg
0.35
0.42
3.84
12.47
0.29
25.22
18.51
16.6
Category Best
1.3
4.07
6.64
16.98
9.75
30.53
21.58
34.23
Category Worst
-0.33
-0.78
1.29
9.11
-10.57
21.26
14.05
-2.28

LIC MF Healthcare Fund Regular G- Latest Dividends

No Records Found

LIC MF Healthcare Fund Regular G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

500

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Cohance Life13,505
Zydus Lifesci.12,957

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology9.72538518.58
EquityApollo HospitalsHealthcare Services5.7967235.11
EquityCiplaPharmaceuticals & Biotechnology5.62312184.96
EquityTorrent Pharma.Pharmaceuticals & Biotechnology5.29131304.67
EquityFortis Health.Healthcare Services4.35421023.83
EquityDivi's Lab.Pharmaceuticals & Biotechnology4.2861583.77
EquityPiramal PharmaPharmaceuticals & Biotechnology4.121983853.63
EquityAlkem LabPharmaceuticals & Biotechnology3.7362123.29
EquityNeuland Labs.Pharmaceuticals & Biotechnology3.6824143.24
EquityAurobindo PharmaPharmaceuticals & Biotechnology3.64313013.21
EquityAbbott IndiaPharmaceuticals & Biotechnology3.459683.04
EquityIpca Labs.Pharmaceuticals & Biotechnology2.87183112.53
EquityMetropolis HealtHealthcare Services2.83114172.49
EquityGland PharmaPharmaceuticals & Biotechnology2.83133512.49
EquityArtemis MedicareHealthcare Services2.701088322.38
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology2.61119942.30
EquityOneSource Speci.Pharmaceuticals & Biotechnology2.59120772.28
EquityNavin Fluo.Intl.Chemicals & Petrochemicals2.5547962.24
EquityDr Agarwal's HeaHealthcare Services2.43496842.14
EquityMankind PharmaPharmaceuticals & Biotechnology2.4085772.11
EquityConcord BiotechPharmaceuticals & Biotechnology2.35123412.07
EquityGlobal HealthHealthcare Services2.33149522.05
EquityMax HealthcareHealthcare Services2.19167751.93
EquitySyngene Intl.Healthcare Services2.00282601.76
EquityJ B Chemicals &Pharmaceuticals & Biotechnology1.9097361.67
EquityAnthem BiosciencPharmaceuticals & Biotechnology1.71184951.51
EquityVinati OrganicsChemicals & Petrochemicals1.6987411.49
EquityAcutaas ChemicalPharmaceuticals & Biotechnology1.5597111.36
EquityLinde IndiaChemicals & Petrochemicals1.1315590.99
Cash & Cash Equivalent
Reverse RepoTREPS-/-5.7905.11
Net CA & OthersNet CA & Others-/--0.140-0.12

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
38,853.80
Trustee/s:
Mr. Pradeep Jagannath Bhi, LIC Mutual Fund Trustee P
Chairman:
NA
CEO / MD:
T.S. Ramakrishnan, Ravi Kumar Jha
CIO:
NA
President:
NA
Director/s:
Raghunandan Maluste, Vijay Sharma, Sanjay Achyutrao Muthal, Praveen Garg
Compliance Officer/s:
NA
Investor Service Officer/s:
Mr.Prashant Thakkar
Fund Manager/s:
Karan Doshi
Auditors:
S.R. Batliboi LLP

OTHER INFORMATION

Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.